<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas14841-bib-0013">
 <label>13</label>
 <mixed-citation publication-type="journal" id="cas14841-cit-0013">
  <string-name>
   <surname>Komatsu</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Ishioka</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Shimada</surname>
   <given-names>K</given-names>
  </string-name>, et al. 
  <article-title>Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin‐based chemotherapy versus combination chemotherapy with S‐1, irinotecan, and bevacizumab as first‐line therapy for metastatic colorectal cancer</article-title>. 
  <source xml:lang="en">BMC Cancer</source>. 
  <year>2015</year>;
  <volume>15</volume>:
  <fpage>626</fpage>.
  <pub-id pub-id-type="pmid">26353772</pub-id>
 </mixed-citation>
</ref>
